Did You Know...
...that in 1800 ether was first used by partyers as a fun diversion? Sniffing the gas led to hilarious and raucous laughter as people watched each other become more and more intoxicated and silly. Several doctors independently realized the value ether would have to anesthetize surgery patients. Of those who claimed rights to the "discovery," none had a happy ending. One had a seizure and died defending his rights. Another spent his life in an asylum because he had been denied acclaim. A third became addicted to chloroform and, in a New York City jail, he soaked a cloth in the drug, severed an artery and bled to death.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7939570 | Controlled-release composition for topical application and a method of delivering an active agent to a substrate A controlled-release composition for topical application to a substrate includes an oil-in-water emulsion and an active agent incorporated into the oil-in-water emulsion. The oil-in-water emulsion is substantially free of lipophilic solvent and is formed by mechanic... | 05/10/2011 |
| 7189407 | Composition for external use A compositions for external use comprising succinoglucan and a water-swelling clay mineral, which is useful particularly as cosmetics. The composition can give a novel feeling upon use which satisfies the diversified requirements by consumers and is excellent in lon... | 03/13/2007 |
| 7153330 | Composition for the oxidation dyeing of keratin fibres, comprising at least one 4,5- or 3,4-diaminopyrazole or a triaminopyrazole and at least one selected mineral compound, and dyeing process The present invention relates to a composition for the oxidation dyeing of keratin fibers, in particular of human keratin fibers such as the hair, comprising at least one oxidation base chosen from 4,5- or 3,4-diaminopyrazoles and triaminopyrazoles, in combination w... | 12/26/2006 |
| 7135442 | Lens care product containing dexpanthenol The present invention relates to contact lens care product comprising dexpanthenol. The invention similarly relates to the usage of a contact lens care compositions of this kind for cleaning and optionally disinfecting contact lenses. ... | 11/14/2006 |
| 7094416 | Facial treatment mask and the process for its preparation It discloses a facial treatment mask that can be applied directly on the user's skin, with improved organoleptic properties, along with a process for preparing the product that serves as a base for the mask. Said product consists of the mixture of two separate phase... | 08/22/2006 |
| 7067140 | Cosmetic composition A non-aqueous cosmetic composition contains (A) activated zeolite, (B) a polyhydric alcohol having a molecular weight not higher than 1,000, and (C) a high molecular compound soluble in the ingredient (B). When shaken upon use, the cosmetic composition permits ready... | 06/27/2006 |
| 7056537 | Treatment of landfill gas The present invention relates to a method of abating hydrogen sulfide gas emitted by or generated in landfills. Certain embodiments of the present invention relate to contacting hydrogen sulfide gas with Fuller's earth or other carrier materials and metals such as s... | 06/06/2006 |
| 7037511 | Hydrous cosmetic or pharmaceutical sticks Cosmetic or dermatological stick preparations, which are finely disperse systems of the water-in-oil type, comprising a) an oil phase which comprises from 10 to 70% by weight, based on the weight of the fatty phase, of fatty and/or wax c... | 05/02/2006 |
| 7011826 | Control of acidosis The present invention relates to a vaccine for the prevention of lactic acidosis in a vertebrate, said vaccine comprising at least one isolated microorganism, or fragment or fragments thereof, wherein said microorganism is capable of producing lactic acid within the... | 03/14/2006 |
| 6972129 | Method for producing cosmetics An objective of the present invention is to provide a method for producing cosmetic products capable of improving a touch of cosmetic products containing powder and exerting the function of the powder sufficiently. In order to accomplish the objective described abov... | 12/06/2005 |
| 6953595 | Inhibitors of apoptosis of nerve cells This invention refers to the preparation for elimination of neuropathies in diabetes. The preparation contains a combination of minerals and plant extracts. By its ionic exchange, the invention reduces considerably the process of apoptosis of nerve-cells, eliminates... | 10/11/2005 |
| 6914073 | Vitamin formulation for cardiovascular health The invention concerns a composition containing a high level of Vitamin E in encapsulated form, preferably as beadlets or spray dried, and a high level of silicates. The composition is compressible into tablets or caplets that do not leach out Vitamin E into the tab... | 07/05/2005 |
| 6893660 | Stable pharmaceutical compositions without a stabilizer Stabilized controlled release pharmaceutical preparations are disclosed in which active ingredient degradation is prevented without the use of a stabilizer. The active ingredient is sealed away from excipients that can adversely affect stability by sealing the excip... | 05/17/2005 |
| 6861075 | Biocidal compositions comprising an aerated gel containing hydrophobic silica A storage-stable biocidal aerated gel composition comprises from 30 to 97% by weight of water, from 0.2 to 5% by weight of a gelling agent selected from xanthan gum, sodium alginate and neutralised carboxyvinyl polymer from 2 to 5% by weight of a fine particulate, h... | 03/01/2005 |
| 6835847 | Phthalic acid diamide, method for the production thereof and the use of the same as a pesticide The invention relates to novel phthalamides of the formula (I) in which disclosure. The invention further relates to a process for preparing these compounds and their use for controlling pests. ... | 12/28/2004 |
| 6814978 | Process for preparing a soft tablet The invention relates to a process for preparing a soft tablet capable of being chewed or disintegrated in the oral cavity. The tablet is prepared by forming a tablet having a friability of less than about 2% from a mixture comprising a pharmaceutically active ingre... | 11/09/2004 |
| 6770778 | N-(4-substituted phenyl)-anthranilic acid hydroxamate esters The present invention relates to oxygenated esters of 4-substituted-phenylamino benzhydroxamic acid derivatives, pharmaceutical compositions, and methods of use thereof. ... | 08/03/2004 |
| 6761905 | Process for the preparation of direct tabletting formulations and aids A thermal adhesion granulation process for preparing direct tabletting formulations or aids is disclosed. The process comprises the step of subjecting all or part of a mixture comprising: A) from about 5 to about 99% by weight of one or more diluent excipient... | 07/13/2004 |
| 6749869 | Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection The mastitis control teat dip composition of the invention provides rapid initial kill, a useful highly pseudoplastic rheology, a barrier/film-forming capacity, a unique antimicrobial composition that is stable over an extended period of time, and unexpected long te... | 06/15/2004 |
| 6740315 | Coated powder and cosmetic prepared by blending the same Coated powder is obtained by applying a material having a refractive index of 1.9 to 3.1 to powder having a refractive index of 1.3 to 1.8 as a core and further applying a material having a refractive index of 1.3 to 1.8 to the coated core. When this powder is used ... | 05/25/2004 |
| 6699510 | Acidic aqueous chlorite teat dip with improved visual indicator stability, extended shelf life, sanitizing capacity and tissue protection The mastitis control teat dip composition having a visible indicator aspect of the invention provides a softening, soothing, smoothing, relaxing property, a rapid initial kill, a useful highly pseudoplastic rheology, a barrier/film-forming capacity, a uni... | 03/02/2004 |
| 6692767 | Solid solution beadlet Disclosed is a beadlet comprising (i) a hydrophobic long chain fatty acid or ester material; (ii) a surfactant; and (iii) a therapeutic agent which in admixture form a solid solution at room temperature. The hydrophobic material preferably has a melting p... | 02/17/2004 |
| 6692771 | Emulsions as solid dosage forms for oral administration Novel emulsion compositions which improve the rate and/or extent of absorption of drugs are disclosed. The novel emulsion compositions of the present invention include drug-containing emulsions adsorbed onto solid particles which may be further formulated... | 02/17/2004 |
| 6689340 | Hair composition containing a polycondensate comprising at least one polyurethane and/or polyurea unit and a polyol The invention relates to hair compositions packaged in aerosol form and comprising, in a cosmetically acceptable medium, a polycondensate, such as a multiblock polymer, comprising at least one polyurethane and/or polyurea unit, at least one polyol, an org... | 02/10/2004 |
| 6685969 | Treatment for ectoparasites Ectoparasites, such as fleas, ticks, mites and lice, are removed from a human or animal host after applying a composition that causes the temperature of the treated area to become higher or lower than normal. In one embodiment, treatment is effected by ap... | 02/03/2004 |
| 6667059 | Odor-masking coating for a pharmaceutical preparation A coating for masking or reducing the detectable presence of certain characteristic odor or odors, taste or tastes of pharmaceutical preparations, particularly Valerian extracts, is described. The coating comprises from one to three coating compartments, ... | 12/23/2003 |
| 6660277 | Gel matrix non-emulsion composition containing two clay gels A cosmetic composition comprising a lipophilic clay gel and a hydrophilic clay gel. The two gels are combined or formed in situ to create a gel matrix. This matrix functions like an emulsion to deliver water and oil to the skin or other surface, but can b... | 12/09/2003 |
| 6649151 | Cosmetic formulation The present invention includes a cosmetic formulation. The cosmetic formulation comprises a plurality of spheres having a first desiccated volume and having a second hydrated volume. The hydrated volume is greater than the desiccated volume.... | 11/18/2003 |
| 6635281 | Gastric retaining oral liquid dosage form The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of a liquid, active agent formulation to a fluid environment of use. The liquid, active agent formulation ... | 10/21/2003 |
| 6632805 | Methods for using water-stabilized organosilanes A method of dyeing and treating a substrate using a water-stabilized organosilane. A method of antimicrobially treating a food article. A method of antimicrobially coating a fluid container. A method of antimicrobially coating a latex medical article.... | 10/14/2003 |
| 6627224 | Low dose entecavir formulation and use Compositions containing a low dose of entecavir are administered on a daily basis to treat hepatitis B virus infection and/or co-infections. Formulations for the oral administration of a low dose of entecavir are provided. Other pharmaceutically active su... | 09/30/2003 |
| 6620432 | Phenytoin sodium pharmaceutical compositions A pharmaceutical composition is provided containing an admixture of phenytoin sodium and an erodible matrix which extends the release of the phenytoin sodium over about a two hour period. The erodible matrix comprises binder(s) and diluent(s) which contro... | 09/16/2003 |
| 6617356 | Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements Suspensions, emulsions or dispersions of therapeutically active agents which are water insoluble or water intolerant such as nutritional supplements, herbal products, drugs, bacteria, yeast, vitamins and minerals are prepared as suspensions in edible vege... | 09/09/2003 |
| 6610673 | Solid dose forms containing bismuth A swallowable, solid dose form composition for treating upper gastrointestinal tract distress containing bismuth subsalicylate, carbonate or bicarbonate salt, disintegrating agent, anionic or nonionic surfactant, and microcrystalline cellulose is describe... | 08/26/2003 |
| 6596300 | Animal feed The present invention includes a method for increasing meat production while reducing fat in ruminant and non-ruminant animals and for increasing egg production in poultry and milk production in ruminant animals. The method includes mixing ingredients tha... | 07/22/2003 |
| 6585986 | Gelling agent and gel compositions A gelation agent or an emulsifying agent is provided which is obtained by mixing a water swelling clay mineral with a quarternary ammonium salt type cation surfactant and a fatty acid or a higher alcohol which is liquid at normal temperatures. The present... | 07/01/2003 |
| 6576633 | Stable liquid antimicrobial suspension compositions containing quarternaries prepared from hexamethylenetetramine and certain halohydrocarbons Anhydrous, liquid antimicrobial compositions comprising quaternaries 1-(benzyl)-3,5,7-triaza-1-azoniaadamantane chloride, 1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride and the cis- and cis/trans-isomers thereof, 1-(-(2-xylyl))-3,5... | 06/10/2003 |
| 6569407 | Compositions containing a polycondensate comprising at least one polyurethane and/or polyurea unit and a silicone comprising at least one carboxylic function The invention relates to hair compositions comprising, in a cosmetically acceptable medium, a polycondensate comprising at least one polyurethane and/or polyurea unit and a silicone comprising at least one carboxylic function. The invention is also direct... | 05/27/2003 |
| 6569440 | Emitter of semiochemical substances supported on a sepiolite, preparation process and applications The present invention provides an emitter of semiochemical substances that comprising a support and a semiochemical subsistence adsorbed in the same, is characterized in that said support is a sepiolite and in that the retaining force between said sepioli... | 05/27/2003 |
| 6544558 | Pharmaceutical formulations comprised of amoxicillin in combination with clavulanic acid Syrup formulations comprising water and compacted granulates which are mixture of amoxycillin and clavulanic acid, together with an intra-granular disintegrant.... | 04/08/2003 |
